Harpoon Therapeutics, Inc.
HARPDelisted Mar 11, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001708493
Harpoon Therapeutics, Inc. was delisted on Mar 11, 2024; its insiders filed their last Form 4 on Mar 11, 2024; 41 institutions reported holding it in 13F filings for Q4 2023, worth $175.5M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Harpoon Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 44 | 1 | 32 | −11 |
| SharesConverted for a 1-for-10 split | 1.69M | 26.0K | 1.87M | +209.9K (+12.6%) |
| Value | $12.0M | $184.5K | $7.53M | −$4.25M (−36.1%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held Harpoon Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sio Capital Management, LLC | 168,017 | $677.1K | 0.21% |
| Allworth Financial LP | 40 | $162 | 0.00% |
| Qube Research & Technologies Ltd | 5 | $20 | 0.00% |
Sold out (14)
Institutions that held Harpoon Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Bridgeway Capital Management, LLC | 88,000 | $62.5K |
| State Street Corp | 85,232 | $60.5K |
| Sequoia Financial Advisors, LLC | 63,955 | $45.4K |
| Two Sigma Investments, LP | 43,144 | $30.6K |
| Northern Trust Corp | 37,663 | $26.7K |
| Barclays PLC | 33,791 | $24.0K |
| Synovus Financial Corp | 23,000 | $16.3K |
| Jane Street Group, LLC | 16,734 | $11.9K |
| HRT Financial LP | 10,894 | $7.00K |
| Simplex Trading, LLC | 3,743 | $2.00K |
| Federated Hermes, Inc. | 1,133 | $804 |
| BNP Paribas Arbitrage, SA | 428 | $304 |
| FMR LLC | 135 | $96 |
| IFP Advisors, Inc | 29 | – |
Not filed for Q3 2023 yet (1)
Institutions that held Harpoon Therapeutics, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Tekla Capital Management LLC | 259,910 | $184.5K |